• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

5 Questions on CDC Updates to COVID-19 and Flu Vaccine Guidance


Immunization Awareness Month

Updates to CDC recommendations on influenza and COVID-19 vaccines and vaccine formulations will impact your choices during flu season this year.

COVID-19 and Flu Vaccinations: A CDC Recommendations Quiz ©Kateryna_Kon/Shutterstock.com

New COVID-19 and influenza immunization recommendations from the Centers for Disease Control and Prevention (CDC) will affect vaccination decisions made during the 2023-2024 respiratory virus season. The updates reflect changes in the spread of infections as well as in the development of vaccines. The following 5 questions test what you know about recommended vaccines and vaccine formulations for these 2 soon-to-be-prevalent viruses.

Question 1. COVID-19 vaccination is recommended for everyone 6 months and older who is not immunocompromised.

Question 2. Which of the following COVID-19 vaccines is/are not currently recommended?

Question 3. With the development of bivalent COVID-19 vaccines, monovalent vaccines will not be used in 2023.

Question 4. Select recommended option(s) for persons aged ≥18 years who were previously vaccinated with the Janssen adenovirus vector COVID-19 vaccine.

Question 5. Select influenza vaccine(s) preferred by the CDC for those aged ≥65 years.

Sources include the 2023 CDC Immunization Schedules for adult- and children and subsequent, interim considerations of the CDC, as well as recent meetings of the CDC's Advisory Committee on Immunization Practices ( ACIP) and the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC).

Related Videos
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
© 2024 MJH Life Sciences

All rights reserved.